Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-04-4532PMID 15735013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia.

  2004cited by this paper
• Epigenetic Profiling in Chronic Lymphocytic Leukemia Reveals Novel Methylation Targets

  2004cited by this paper
• ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein.

  2004cited by this paper
• The t(8;21) fusion protein contacts co-repressors and histone deacetylases to repress the transcription of the p14ARF tumor suppressor.

  2003cited by this paper
• Chromosomal Translocation t ( l 5 ; 17 ) in Human Acute Promyelocytic Leukemia Fuses RARa with a Novel Putative Transcription Factor , PML

  2003cited by this paper
• Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells

  2003cited by this paper
• Core-binding factors in haematopoiesis and leukaemia

  2002influential reference
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia

  2002cited by this paper
• Cancer Epigenetics and Methylation

  2002cited by this paper
• Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor

  2002cited by this paper
• ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain

  2001cited by this paper
• Molecular and Clinical Advances in Core Binding Factor Primary Acute Myeloid Leukemia: A Paradigm for Translational Research in Malignant Hematology

  2000cited by this paper
• CREB-binding protein and p300: molecular integrators of hematopoietic transcription.

  2000cited by this paper
• AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.

  2000cited by this paper
• Positive and Negative Regulation of Granulocyte-Macrophage Colony-Stimulating Factor Promoter Activity by AMLI-Related Transcription Factor , PEBP 2

  2000cited by this paper
• Functional and Physical Interactions between AML1 Proteins and an ETS Protein, MEF: Implications for the Pathogenesis of t(8;21)-Positive Leukemias

  1999cited by this paper
• Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

  1999cited by this paper
• Gene silencing by methyl-CpG-binding proteins.

  1998cited by this paper
• ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.

  1998cited by this paper
• Role of the histone deacetylase complex in acute promyelocytic leukaemia

  1998cited by this paper
• Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia

  1998cited by this paper
• Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

  1998influential reference
• Characterization of the ETO and AML1–ETO proteins involved in the 8;21 translocation in acute myelogenous leukemia

  1998cited by this paper
• Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

  1998cited by this paper
• The AML1-MTG8 Leukemic Fusion Protein Forms a Complex with a Novel Member of the MTG8(ETO/CDR) Family, MTGR1

  1998cited by this paper
• Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO

  1998cited by this paper
• Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL

  1998cited by this paper
• Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

  1998cited by this paper
• The MYND Motif Is Required for Repression of Basal Transcription from the Multidrug Resistance 1 Promoter by the t(8;21) Fusion Protein

  1998cited by this paper
• AML1A and AML1B can transactivate the human IL-3 promoter.

  1997cited by this paper
• Gene expression of interleukin‐3 and granuloeyte maerophage colony‐stimulating factor in circulating CD4+ T cells in acute severe asthma

  1996cited by this paper
• The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal

  1996cited by this paper
• The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse

  1996cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B.

  1995cited by this paper
• Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2.

  1995cited by this paper
• Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1)

  1994influential reference
• The t(8;21) translocation in acute myeloid leukemia results in production of an AML1‐MTG8 fusion transcript.

  1993cited by this paper
• Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions

  1993cited by this paper
• Interleukin-3 and hematopoiesis.

  1992cited by this paper
• Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.

  1992cited by this paper
• Interleukin-3 and Hematopoiesis (Part 1 of 2)

  1992cited by this paper
• Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.

  1992cited by this paper

• DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity.

  2025cites this paper
• Acute myeloid leukemia with t(8;21) translocation: Molecular pathogenesis, potential therapeutics and future directions.

  2025cites this paper
• Decoding the AML1/ETO Translocation Cipher: In-depth Exploration into the Pathogenesis and Cutting-edge Therapeutic Strategies of t(8;21) Acute Myeloid Leukemia.

  2025cites this paper
• VEGFD/VEGFR3 signaling contributes to the dysfunction of the astrocyte IL-3/microglia IL-3Rα cross-talk and drives neuroinflammation in mouse ischemic stroke

  2024cites this paper
• Identification of epigenetic modifiers essential for growth and survival of AML1/ETO‐positive leukemia

  2024cites this paper
• Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study

  2024cites this paper
• DNA methylation landscape reveals LIN7A as a decitabine-responsive marker in patients with t(8;21) acute myeloid leukemia

  2023cites this paper
• Aberrant DNA methylation in t(8;21) acute myeloid leukemia

  2022influential citation
• DNA methyltransferase-1 in acute myeloid leukaemia: beyond the maintenance of DNA methylation

  2022cites this paper
• Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors

  2021cites this paper
• AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms

  2021cites this paper
• An Assessment on Ethanol-Blended Gasoline/Diesel Fuels on Cancer Risk and Mortality

  2021cites this paper
• The RUNX1/RUNX1T1 network: translating insights into therapeutic options

  2020cites this paper
• Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy

  2020cites this paper
• High throughput screening identifies SOX2 as a super pioneer factor that inhibits DNA methylation maintenance at its binding sites

  2020cites this paper
• t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming

  2020cites this paper
• Epigenetics in Health and Disease.

  2020cites this paper
• Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia

  2019cites this paper
• RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia

  2019cites this paper
• Development and Characterisation of an AML1/ETO Murine Bone Marrow Transplantation Leukaemia Model

  2019cites this paper
• DNA‐modifying Enzymes

  2019cites this paper
• Characterization of a more clinically relevant human leukemia xenograft model to examine perturbation of MET/SAM metabolism as a novel therapeutic paradigm for MLL-R leukemia in vivo.

  2019cites this paper
• Transkriptionelle Regulation des microRNA Clusters 144-451 während der Hämatopoese sowie Leukämogenese

  2019influential citation
• Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription

  2019cites this paper
• Methylation-associated silencing of BASP1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia

  2018cites this paper
• Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma

  2018cites this paper
• Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association

  2018cites this paper
• AML1-ETO promotes SIRT1 expression to enhance leukemogenesis of t(8;21) acute myeloid leukemia.

  2017cites this paper
• Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia

  2017cites this paper
• RUNX1-ETO Leukemia.

  2017cites this paper
• Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment.

  2017cites this paper
• A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.

  2017influential citation
• Small-molecule Inhibitors of Epigenetic Mutations as Compelling Drugtargets for Myelodysplastic Syndromes.

  2017cites this paper
• Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia

  2017cites this paper
• New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins

  2016cites this paper
• On the potential role of DNMT1 in acute myeloid leukemia and myelodysplastic syndromes: not another mutated epigenetic driver

  2016cites this paper
• [Aberrant DNA methylation and its targeted therapy in acute myeloid leukemia].

  2016cites this paper
• Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B study (CALGB 10503)

  2016cites this paper
• Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.

  2016cites this paper
• Proscillaridin A effects on histone acetylation and C-MYC degradation in acute lymphoblastic leukemia

  2016cites this paper
• DNMT3A mutations in acute myeloid leukemia

  2016cites this paper
• Increased DNA methylation of Dnmt3b targets impairs leukemogenesis.

  2016cites this paper
• Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia

  2015cites this paper
• ADVANCES IN ACUTE MYELOID LEUKEMIA Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia

  2015cites this paper
• Series ADVANCES IN ACUTE MYELOID LEUKEMIA Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia

  2015cites this paper
• Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.

  2015cites this paper
• Regulation of DNA methylation dictates Cd4 gene expression during development of helper and cytotoxic T cell lineages

  2015cites this paper
• Epigenetic inhibitors.

  2015cites this paper
• PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia.

  2015cites this paper
• Homéostasie cellulaire du fer dans les cellules leucémiques myéloïdes

  2015influential citation
• Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

  2014cites this paper
• Allelic methylation status of CpG islands on chromosome 21q in patients with Trisomy 21.

  2014cites this paper
• RUNX1T1/MTG8/ETO gene expression status in human t(8;21)(q22;q22)-positive acute myeloid leukemia cells.

  2014cites this paper
• Origins of aberrant DNA methylation in acute myeloid leukemia

  2014cites this paper
• AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation

  2014cites this paper
• AcuteMyeloid Leukemia with the t ( 8 ; 21 ) Translocation : Clinical Consequences and Biological Implications

  2014cites this paper
• Mouse Models to Study DNA Methylation in Cancer Research

  2014cites this paper
• Epigenetic Modifications Mediated by the AML1/ETO and MLL Leukemia Fusion Proteins

  2014cites this paper
• Epigenesis in acute myeloid leukemia: an update.

  2013cites this paper
• Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer

  2013cites this paper
• Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells

  2013cites this paper
• Aberrant epigenetic regulators control expansion of human CD34+ hematopoietic stem/progenitor cells

  2013cites this paper
• Hematopoietic Stem and Progenitor Cells Acquire Distinct DNA-Hypermethylation During in vitro Culture

  2013cites this paper
• Rôle du fer et des espèces réactives de l'oxygène dans la prolifération et la différenciation des leucémies aigües myéloblastiques : caractérisation du système régulateur IRE-IRP dans l'homéostasie du fer de deux lignées leucémiques humaines

  2013cites this paper
• DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding.

  2013cites this paper
• The Etiology of Acute Leukemia

  2013cites this paper
• MuPIT interactive: webserver for mapping variant positions to annotated, interactive 3D structures

  2013cites this paper
• Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3

  2013cites this paper
• Combined gene expression and DNA occupancy profiling as a strategy to identify therapeutic target(s) in t(8;21) acute myeloid leukemia.

  2013cites this paper
• DNA Methylation in Acute Leukemia

  2012cites this paper
• The Genomics of Acute Myeloid Leukaemia An Investigation into the Molecular Pathogenesis of Acute Myeloid Leukaemia with t(8;21)

  2012cites this paper
• Gene Expression Analysis by DNA Microarray in Papillary and Follicular Differentiated Thyroid Cancer

  2012cites this paper
• Cancer Cell Signaling Pathways Targeted by Spice-Derived Nutraceuticals

  2012cites this paper
• Interindividual variability and co-regulation of DNA methylation differ among blood cell populations

  2012cites this paper
• Epigenetics advancing personalized nanomedicine in cancer therapy.

  2012cites this paper
• RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.

  2012cites this paper
• Methylation in haematological malignancies : techniques and prospects

  2012cites this paper
• Novel Targeted Therapeutics for Acute Myeloid Leukemia

  2012cites this paper
• Induction of differentiation and apoptosis in leukaemic cell lines by the novel benzamide family histone deacetylase 2 and 3 inhibitor MI-192.

  2012cites this paper
• Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications

  2011cites this paper
• Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer

  2011cites this paper
• DNA methylation as a pathogenic event and as a therapeutic target in AML.

  2011cites this paper
• Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?

  2011cites this paper
• Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia.

  2011cites this paper
• Dynamics of epigenetic modifications in leukemia.

  2011cites this paper
• Epigenetic mechanisms in acute myeloid leukemia.

  2011cites this paper
• Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects

  2011cites this paper
• The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO

  2011cites this paper
• myeloid leukemia Heterochromatic gene repression of the retinoic acid pathway in acute

  2011cites this paper
• Emerging targeted therapies for pediatric acute myeloid leukemia.

  2011cites this paper
• Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040

  2011cites this paper
• Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO (RUNX1/RUNX1T1), during myeloid differentiation

  2011cites this paper
• Deregulated transcription factors in leukemia

  2011cites this paper
• Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.

  2011cites this paper
• Leukaemogenesis: more than mutant genes

  2010cites this paper
• DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights.

  2010cites this paper
• Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex.

  2010cites this paper
• Molecular diagnosis of acute myeloid leukemia

  2010cites this paper
• DNMT3A mutations in acute myeloid leukemia.

  2010cites this paper
• The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer

  2010cites this paper